Seizure Medications Hope Offers To Patients Wth Frequent Uncontrollable:
A new type of anti-epilepsy medication that selectively targets proteins in the brain that control excitability may significantly reduce seizure Medications frequency in people whose recurrent seizures have been resistant to even the latest medications, new Johns Hopkins-led research suggests.
“Many other drugs to treat frequent seizure Seizure Medications have been released in the last 10 years and for many people, they just don’t work,” says study leader Gregory L. Krauss, M.D., a professor of neurology at the Johns Hopkins University School of Medicine. “For a drug-resistant population that has run out of options, this study is good news. These are patients who are tough to treat and are fairly desperate.”Perampanel is the first in a new class of drugs that appears to blunt an excitatory response in the brain by inhibiting a specific form of glutamate receptor called an AMPA receptor and therefore reducing seizures without causing major side effects. Other drugs targeting all three forms of glutamate receptors in the brain have tended to make patients too sleepy to function, even putting them in comas.